Alcidion (ASX:ALC) share price hits 52-week high on record sales

The Alcidion (ASX:ALC) share price has pushed nearly 9% higher after the company reported strong growth underpinned by an upbeat outlook.

| More on:
A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Alcidion Group Ltd (ASX: ALC) shares are on the rise today after the company recorded one of its strongest sales periods to date. At the time of writing, the Alcidion share price has jumped 8.7% to 25 cents.

Let's take a look at how the tech company has been performing.

Alcidion share price surges on strong earnings 

The Alcidion share price is running higher today following the company delivering strong earnings growth during the first half of FY21 (1H21). Alcidion reported that revenue for the period increased by 36% to $11.1 million. 

The company added $17.4 million in contracted revenue in the first half, one of its strongest sales periods to date. A further $23.0 million of sold revenue will also be recognised over the next five years from FY22 to FY26. 

Significant contracts were signed in the United Kingdom and Australia, including with NHS Trust for Alcidion's largest-ever smart clinical solution, Miya Precision. Other significant contract wins include 12-month contracts signed with New South Wales Government local health districts Murrumbidgee and Sydney. 

Strong revenue growth also translated into an improved earnings before interest, tax, depreciation, and amortisation (EBITDA) loss of $912,000 compared to a $1.7 million EBITDA loss in 1H20. 

Upbeat outlook  

Alcidion believes it is advantageously positioned for the second half of FY21, with the health IT sales environment progressively returning to pre-COVID-19 levels. 

The company's current sales revenue is growing strongly and is on track to surpass FY20 revenue. Contracted revenue in FY21 is already 17% higher than the year prior with four months of the year still remaining. 

The company is upbeat about its sales pipeline, citing new and existing customers in all markets being underpinned by a strong recovery in health IT procurement. 

Company snapshot

Alcidion helps healthcare organisations leverage the power of technology to create a clinically relevant environment with digitally enabled care. The company's flagship product is its Miya Precision solution that facilitates multiple clinical and operational applications. 

Over the past twelve months, the Alcidion share price has jumped by nearly 39%. Year to date, Alcidion shares are trading nearly 32% higher.

Based on the current share price, the company commands a market capitalisation of around $248 million.

Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd. The Motley Fool Australia has recommended Alcidion Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Woman on the phone at a hardware store.
Broker Notes

Up 21% this year, how much further upside does Macquarie tip for Metcash shares?

Metcash shares tick many boxes for investors.

Read more »

A young couple sits at their kitchen table looking at documents with a laptop open in front of them.
Opinions

Why I'd buy these top ASX 200 shares next

Growing businesses are compelling. These two are growing significantly.

Read more »

Smiling man with phone in wheelchair watching stocks and trends on computer
Share Market News

5 things to watch on the ASX 200 on Tuesday

A much better session is expected for Aussie investors today.

Read more »

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough start to the week this Monday.

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Broker Notes

Guess which popular ASX 200 stock Bell Potter just downgraded

Let's see what the broker is saying on this blue chip.

Read more »

Crude oil barrels rocketing.
ETFs

Why did the BetaShares Crude Oil ETF just spike 4%?

This ETF is attracting buyers in today's seller's market.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why BWP, Metcash, Resolute Mining, and SHAPE shares are pushing higher today

These shares are starting the week on a positive note. But why?

Read more »